Le Lézard
Classified in: Science and technology
Subject: PDT

BlueCat DNS Edge delivers visibility, control and detection to enterprise network and cybersecurity teams


With DNS exploit attacks surging, BlueCat releases new DNS security software that detects internal threats and secures vital assets.

TORONTO, May 23, 2018 /CNW/ -- Today, BlueCat, the Enterprise DNS company, announced powerful new capabilities for BlueCat DNS Edgetm (Edge), a solution that leverages existing DNS infrastructure to help cybersecurity and networking teams detect and block cyber attacks. The new capabilities add a much-needed layer of defense for corporate networks under siege from an explosion of malware attacks and their skyrocketing cost. According to industry research, 91% of malware uses the DNS protocol for command and control, data exfiltration or lateral movement on a corporate network.

BlueCat Logo (PRNewsfoto/BlueCat)

"Networking and cybersecurity teams are under pressure to gain control of their network infrastructure and greatly increase actionable cyber intelligence," said Michael Harris, CEO of BlueCat. "The solution lies hidden in billions of DNS queries and responses. As the leading provider of Enterprise DNS solutions for the world's largest organizations, BlueCat is in a unique position to help customers identify, control and reduce the attack surface ? especially for exploits happening inside the firewall."

Stephen Frank, Director, Technology and Security at NHL Players Association uses Edge to secure player information from DNS exploits and exfiltration. "The NHLPA faces cyber challenges that many organizations don't. For example, we see so many international domains because of the diverse nationalities of players," says Frank. "As a best-of-breed DNS security offering, Edge gives us a whole new level of visibility into network activity that helps us distinguish malicious activity from good."

Edge helps organizations:

The latest version of Edge also includes new DNS-routing policies using multi-namespaces to introduce unique flexibility for administrators to configure their DNS resolution path, lighten the load on the WAN and web proxies, and eliminate duplication across namespaces. Additionally, new dashboard improvements make it easier for administrators to spot anomalies in DNS query data.

About BlueCat

BlueCat is the Enterprise DNS Companytm. The largest global enterprises trust BlueCat to provide the foundation for digital transformation strategies such as cloud migration, virtualization and cybersecurity. Our Enterprise DNS platform improves control and compliance across entire networks, enabling organizations to centralize and automate DNS services for security and operational efficiency. For more information, please visit www.bluecatnetworks.com.

 

SOURCE BlueCat


These press releases may also interest you

at 02:08
Homestyler, a leading all-in-one 3D Design platform and creative community for global designers invested by Easyhome New Retail Group and Alibaba Group, successfully hosted the Homestyler Global Partners Conference and Gorgeous Home Imported Brand...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. . Juniper Re will...

at 02:00
CACI is delighted to announce that its Cygnum software will be used by the Environment Agency as a logistics planning tool to schedule its workforce and assets in the preparation of and response to incidents across England ranging from small...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: